Breaking News Instant updates and real-time market news.

AERI

Aerie Pharmaceuticals

$11.88 /

-1.29 (-9.79%)

, BHC

Bausch Health

$13.73 /

-0.4 (-2.83%)

09:03
03/23/20
03/23
09:03
03/23/20
09:03

SunTrust lowers price targets among Pharmaceuticals due to COVID-19

SunTrust analyst Gregory Fraser has lowered his price targets in the Pharmaceuticals group to reflect the potential impact on demand due to the evolving COVID-19 pandemic. The analyst notes that his covered companies have not yet adjusted or suspended guidance, but he believes it is "prudent" to proactively anticipate headwinds in demand over the coming quarters. Among the companies with the largest changes, Fraser lowers his price target on Aerie Pharma (AERI) to $26 from $31, on Bausch Health (BHC) to $25 from $31, on Colegium Pharma (COLL) to $24 from $27, on Evolus (EOLS) to $18 from $25, on Jazz Pharma (JAZZ) to $155 from $166, on Pacira BioSciences (PCRX) to $54 from $62, on Teva (TEVA) to $11 from $13, and on Zoetis (ZTS) to $112 from $145.

AERI

Aerie Pharmaceuticals

$11.88 /

-1.29 (-9.79%)

BHC

Bausch Health

$13.73 /

-0.4 (-2.83%)

COLL

Collegium Pharmaceutical

$14.29 /

-0.38 (-2.59%)

EOLS

Evolus

$3.65 /

-0.265 (-6.78%)

JAZZ

Jazz Pharmaceuticals

$96.36 /

-8.41 (-8.03%)

PCRX

Pacira

$31.44 /

-1.06 (-3.26%)

TEVA

Teva

$7.27 /

+0.085 (+1.18%)

ZTS

Zoetis

$101.01 /

-1.31 (-1.28%)

  • 24

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 31

    Mar

  • 16

    Aug

AERI Aerie Pharmaceuticals
$11.88 /

-1.29 (-9.79%)

02/21/20 JMP Securities
Aerie Pharmaceuticals price target lowered to $35 from $41 at JMP Securities
02/13/20 Piper Sandler
Aerie Pharmaceuticals price target lowered to $45 from $48 at Piper Sandler
01/10/20 BofA
Aerie Pharmaceuticals initiated with a Neutral at BofA
01/09/20 SunTrust
Aerie Pharmaceuticals initiated with a Buy at SunTrust
BHC Bausch Health
$13.73 /

-0.4 (-2.83%)

03/23/20 Wells Fargo
Bausch Health price target lowered to $17 from $32 at Wells Fargo
03/23/20 H.C. Wainwright
Bausch Health recent share selloff looks overdone, says H.C. Wainwright
03/17/20 RBC Capital
Bausch Health price target lowered to $26 from $31 at RBC Capital
02/20/20 JPMorgan
Bausch Health seems much more open to split or spinoff, says JPMorgan
COLL Collegium Pharmaceutical
$14.29 /

-0.38 (-2.59%)

02/19/20 Jefferies
Collegium Pharmaceutical resumed with a Buy at Jefferies
02/12/20 Piper Sandler
Collegium price target raised to $35 from $27 at Piper Sandler
02/04/20 Piper Sandler
Piper reiterates Overweight on Collegium after physician survey
01/15/20 Gabelli
Nektar committee vote eliminates potential Collegium competitor, says Gabelli
EOLS Evolus
$3.65 /

-0.265 (-6.78%)

03/04/20 Mizuho
Mizuho sees no change to Evolus story as focus on ITC case drives weakness
03/04/20 Stifel
Stifel remains supportive of Evolus' position in ITC case
03/04/20 Cantor Fitzgerald
Evolus 'unduly' weighed down by ITC case headlines, says Cantor Fitzgerald
02/25/20 Cantor Fitzgerald
Evolus launches, new products should drive stock higher, says Cantor Fitzgerald
JAZZ Jazz Pharmaceuticals
$96.36 /

-8.41 (-8.03%)

03/12/20 Bernstein
Jazz Pharmaceuticals upgraded to Outperform from Market Perform at Bernstein
02/26/20 RBC Capital
Jazz Pharmaceuticals price target lowered to $164 from $184 at RBC Capital
02/26/20 Oppenheimer
Jazz Pharmaceuticals price target lowered to $154 from $183 at Oppenheimer
02/26/20 Cowen
Jazz Pharmaceuticals lowered his price target to $165 from $200 at Cowen
PCRX Pacira
$31.44 /

-1.06 (-3.26%)

03/23/20 RBC Capital
Pacira price target lowered to $56 from $65 at RBC Capital
03/23/20 Piper Sandler
Pacira price target lowered to $49 from $60 at Piper Sandler
03/20/20 SVB Leerink
Pacira upgraded to Outperform from Market Perform at SVB Leerink
03/20/20 SVB Leerink
Pacira upgraded to Outperform from Market Perform at SVB Leerink
TEVA Teva
$7.27 /

+0.085 (+1.18%)

03/09/20 Oppenheimer
Amgen price target lowered to $250 from $256 at Oppenheimer
02/26/20 H.C. Wainwright
H.C. Wainwright reiterates $51 price target on Amarin shares post Q4 results
02/25/20 Wells Fargo
Emergent BioSolutions price target raised to $75 from $66 at Wells Fargo
02/24/20 Edward Jones
Teva downgraded to Sell from Hold at Edward Jones
ZTS Zoetis
$101.01 /

-1.31 (-1.28%)

03/13/20 Cleveland Research
Demand for Zoetis' Simparica Trio 'robust,' says Cleveland Research
02/14/20 SunTrust
Zoetis price target raised to $145 from $130 at SunTrust
01/10/20 Raymond James
Zoetis' premium valuation vs. peers likely to persist, says Raymond James
01/09/20 Raymond James
Zoetis initiated with a Market Perform at Raymond James

TODAY'S FREE FLY STORIES

Conference/Events
Jefferies software/Internet analyst to hold an analyst/industry conference call » 15:02
03/29/20
03/29
15:02
03/29/20
15:02

Software & Internet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Jefferies technology analyst to hold an analyst/industry conference call » 14:55
03/29/20
03/29
14:55
03/29/20
14:55
GLW

Corning

$20.73 /

-1.09 (-5.00%)

Technology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Ambarella participates in a conference call with Jefferies » 14:49
03/29/20
03/29
14:49
03/29/20
14:49
AMBA

Ambarella

$47.79 /

-2.31 (-4.61%)

U.S. Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Par Technology participates in a conference call with Jefferies » 14:45
03/29/20
03/29
14:45
03/29/20
14:45
PAR

Par Technology

$13.10 /

-1.51 (-10.34%)

Software Analyst Samana…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
WOW! CEO hospitalized with COVID-19 » 14:32
03/29/20
03/29
14:32
03/29/20
14:32
WOW

WideOpenWest

$4.03 /

-0.52 (-11.43%)

WOW! CEO Teresa Elder,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Amazon entices warehouse workers to grocery unit with higher pay, Reuters says » 13:32
03/29/20
03/29
13:32
03/29/20
13:32
AMZN

Amazon.com

$1,900.79 /

-52.4 (-2.68%)

Amazon is offering higher…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
WeWork cuts another 250 jobs, Bloomberg reports » 13:20
03/29/20
03/29
13:20
03/29/20
13:20
WE

We Company

$0.00 /

+ (+0.00%)

WeWork continued to cut…

WeWork continued to cut more staff as part of a months-long effort to lower expenses after its failed initial public offering last year, the company said, Bloomberg's Ellen Huet and Gillian Tan report. The company axed about 250 jobs in its development department, according to two people familiar with the matter. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
U.S. virus deaths could reach 200,000 as supplies run short, Reuters reports » 12:56
03/29/20
03/29
12:56
03/29/20
12:56
SPY

SPDR S&P 500 ETF Trust

$253.79 /

-7.61 (-2.91%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

U.S. deaths from…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Morgan Stanley economists/strategists to hold analyst/industry conference call » 12:55
03/29/20
03/29
12:55
03/29/20
12:55

US Fixed Income Analyst…

US Fixed Income Analyst Tirupattur, Biotech Analyst Harrison, US Public Policy & Municipal Strategist Zezas, US & European Credit Strategist Sankaran and Chief US Equity Strategist Wilson provide their viewpoints on the opportunities and risks across asset classes on an Analyst/Industry conference call to be held on March 29 at 2 pm.

Periodicals
White House-led airlift of medical supplies arrives in NY, Reuters reports » 12:51
03/29/20
03/29
12:51
03/29/20
12:51
SPY

SPDR S&P 500 ETF Trust

$253.79 /

-7.61 (-2.91%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

A planeload of…

A planeload of desperately needed medical supplies arrived in New York from China on Sunday, the first in a series of flights over the next 30 days organized by the White House to help fight the coronavirus, Reuters' Steve Holland reports, citing a White House official. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Partisan divide on coronavirus next steps, Reuters reports » 12:47
03/29/20
03/29
12:47
03/29/20
12:47
SPY

SPDR S&P 500 ETF Trust

$253.79 /

-7.61 (-2.91%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

Fresh partisan divisions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Jefferies Group CFO Peg Broadbent dies due to coronavirus complications » 12:43
03/29/20
03/29
12:43
03/29/20
12:43
JEF

Jefferies Financial Group

$14.33 /

-0.78 (-5.16%)

Jefferies Financial Group…

Jefferies Financial Group announced that Peg Broadbent, the CFO of Jefferies Group, has passed away from coronavirus complications. Teri Gendron, CFO of Jefferies Financial Group, has been appointed as the interim CFO and Chief Accounting Officer of Jefferies Group.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Medtronic announces data from SPYRAL HTN-OFF MED Pivotal Trial » 12:41
03/29/20
03/29
12:41
03/29/20
12:41
MDT

Medtronic

$89.87 /

-2 (-2.18%)

Medtronic announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Edwards Lifesciences announces 2-year results from randomized PARTNER 3 trial » 12:37
03/29/20
03/29
12:37
03/29/20
12:37
EW

Edwards Lifesciences

$198.40 /

-1.49 (-0.75%)

Edwards Lifesciences…

Edwards Lifesciences announced 2-year results of the randomized PARTNER 3 trial comparing treatment with the SAPIEN 3 valve to surgery in patients with severe symptomatic aortic stenosis at low risk of death from surgery. Transcatheter aortic valve replacement with the SAPIEN 3 valve continued to demonstrate favorable results for low-risk patients over surgery. TAVR resulted in a 37% reduction in the event rate for the primary endpoint of the trial, which was a composite of all-cause mortality, all stroke and rehospitalization at two years. Death and stroke rates were both low between TAVR and surgical aortic valve replacement at two years, and TAVR patients experienced a significantly lower rate of rehospitalization. The PARTNER 3 trial randomized 1,000 patients at 71 centers between March 2016 and October 2017. Low-risk patients were assigned to undergo either TAVR with the SAPIEN 3 valve or surgery with any commercially available surgical valve. The SAPIEN 3 valve was approved in August 2019 in the U.S. for the treatment of low risk patients with severe, symptomatic AS. To date, more than 650,000 patients around the world have benefitted from TAVR.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Medtronic announces data from Low-Risk Bicuspid study assessing Evolut TAVR » 12:34
03/29/20
03/29
12:34
03/29/20
12:34
MDT

Medtronic

$89.87 /

-2 (-2.18%)

Medtronic announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Aristocrat Leisure upgraded to Buy from Neutral at Goldman Sachs » 08:46
03/29/20
03/29
08:46
03/29/20
08:46
ARLUF

Aristocrat Leisure

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Kane Hannan upgraded Aristocrat Leisure to Buy from Neutral with a A$29 price target. There is significant near-term earnings uncertainty in the company's land-based businesses from global casino closures, but the stock's 48% since February is unjustified, Hannan tells investors in a research note. Aristorcat will emerge in a "materially stronger" competitive position, its digital growth is accelerating, and its balance sheet issues are "overplayed," contends the analyst.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Huazhu Group upgraded to Buy from Neutral at Goldman Sachs » 08:43
03/29/20
03/29
08:43
03/29/20
08:43
HTHT

Huazhu Group

$27.81 /

-2.08 (-6.96%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Morgan Stanley economists/strategists to hold analyst/industry conference call » 04:55
03/29/20
03/29
04:55
03/29/20
04:55

US Fixed Income Analyst…

US Fixed Income Analyst Tirupattur, Biotech Analyst Harrison, US Public Policy & Municipal Strategist Zezas, US & European Credit Strategist Sankaran and Chief US Equity Strategist Wilson provide their viewpoints on the opportunities and risks across asset classes on an Analyst/Industry conference call to be held on March 29 at 2 pm.

Conference/Events
Preferred Apartment management to meet with JMP Securities » 04:55
03/29/20
03/29
04:55
03/29/20
04:55
APTS

Preferred Apartment

$7.44 /

-0.22 (-2.87%)

Meetings to be held in…

Meetings to be held in the Midwest March 30-31 hosted by JMP Securities.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Smith Micro participates in a conference call hosted by B. Riley FBR » 04:55
03/29/20
03/29
04:55
03/29/20
04:55
SMSI

Smith Micro

$4.22 /

+ (+0.00%)

Conference call with…

Conference call with management to be held on March 30 hosted by B. Riley FBR.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Upland Software participates in a conference call with Jefferies » 17:02
03/28/20
03/28
17:02
03/28/20
17:02
UPLD

Upland Software

$24.51 /

-1.81 (-6.88%)

Software & Internet…

Software & Internet Analyst Thill holds a conference call with Chairman & CEO McDonald and CFO Hill on April 1 at 10 am hosted by Jefferies.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Jefferies software/Internet analyst to hold an analyst/industry conference call » 16:55
03/28/20
03/28
16:55
03/28/20
16:55

Software and Internet…

Software and Internet Analyst Thill, along with Microsoft Cloud Expert Mary Jo Foley, discusses COVID-19 trends on the industry on an Analyst/Industry conference call to be held on March 31 at 11 am.

Conference/Events
Teck Resources to host conference call » 16:46
03/28/20
03/28
16:46
03/28/20
16:46
TECK

Teck Resources

$6.51 /

-1.025 (-13.61%)

Conference call to…

Conference call to provide the Company's QB2 Project Update and Annual Business Review will be held on April 1 at 1 pm. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Sintx Technologies to host business news update conference call » 16:34
03/28/20
03/28
16:34
03/28/20
16:34
SINT

Sintx Technologies

$0.43 /

+0.0922 (+27.29%)

Business news update…

Business news update conference call will be held on April 2 at 11 am. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Neonode to host conference call » 16:30
03/28/20
03/28
16:30
03/28/20
16:30
NEON

Neonode

$1.57 /

-0.08 (-4.85%)

Management to hold a…

Management to hold a strategic review conference call on April 2 at 7 am. Webcast Link

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.